Toggle Offcanvas
...
 
Tofacitinib Tenders

Tofacitinib Tenders

View Tofacitinib tenders, RFPs and contracts. Bid on readily available Tofacitinib tenders with the best and most comprehensive tendering platform, since 2002.

Bidding for Tofacitinib tenders is extremely lucrative for companies of all sizes. Tendering authorities and private companies release thousands of contracts worth millions for procurement of Tofacitinib.

Global Tenders stands out as the largest platform dedicated to pharmaceutical tenders and government contracts. Boasting over 20 years of experience in the tender business, GlobalTenders offers the most extensive and reliable Tenders/RFPs/Contracts Database available. The platform aggregates contracts from both public and private sources, connecting with a vast network of over half a million buyers. Employing advanced artificial intelligence, our meticulous process involves gathering information from over a hundred thousand sources. The data is then intelligently categorized into thousands of subcategories for easy filtering and presenting it in a user-friendly format for quick comprehension.

In addition to tender information, we offer in-depth Tofacitinib market analysis, bid consultancy services, and insights into top bidders and winners.

Sign up now to get instant access to unlimited Tofacitinib tenders, advanced search filters, market analysis, industry trends, tender training and 24/7 customer support.

33 Live Notices for Tofacitinib Tenders

Showing 1 to 20

Open House Pharmaceutical Discounts On The Active Ingredient Tofacitinib, Atc L04Af01
country Germany
posting date13 Mar 2025
deadline28 Feb 2027
Open House Pharmaceutical Discounts On The Active Ingredient Tofacitinib, Atc L04Af01
country Germany
posting date13 Mar 2025
deadline28 Feb 2027
Supply of Medicine and Medical / Surgical equipments : Tofacitinib Tablet 5mg etc .
country Sri Lanka
posting date13 Mar 2025
deadline23 Apr 2025
Supply of Medicine and Medical / Surgical equipments : Tofacitinib Tablet 5mg etc .
country Sri Lanka
posting date13 Mar 2025
deadline23 Apr 2025
Completion Of Non-Exclusive Discount Agreements According To §130A (8) Sgb V On Various Active Ingredient/En/Combinations With Any Final Option Within The Framework Of The So-Called Open House Procedure
country Germany
posting date12 Mar 2025
deadline05 Dec 2025
Completion Of Non-Exclusive Discount Agreements According To §130A (8) Sgb V On Various Active Ingredient/En/Combinations With Any Final Option Within The Framework Of The So-Called Open House Procedure
country Germany
posting date12 Mar 2025
deadline05 Dec 2025
Immunopreparaty 2025
country Czech Republic
posting date07 Mar 2025
deadline09 Apr 2025
Immunopreparaty 2025
country Czech Republic
posting date07 Mar 2025
deadline09 Apr 2025
A Medicinal Product With The Active Substance Tofacitinib Citrate
country Czech Republic
posting date17 Feb 2025
deadline18 Mar 2025
A Medicinal Product With The Active Substance Tofacitinib Citrate
country Czech Republic
posting date17 Feb 2025
deadline18 Mar 2025
Purchase And Successive Delivery Of Medicinal Products For Drug And Chemotherapy Programs
country Poland
posting date12 Feb 2025
deadline17 Mar 2025
Purchase And Successive Delivery Of Medicinal Products For Drug And Chemotherapy Programs
country Poland
posting date12 Feb 2025
deadline17 Mar 2025
Open House Original Discount Agreements 2024-12 - Tofacitinib
country Germany
posting date18 Nov 2024
deadline31 Dec 2026
Open House Original Discount Agreements 2024-12 - Tofacitinib
country Germany
posting date18 Nov 2024
deadline31 Dec 2026
Open House Original Discount Agreements 2024-12 - Tofacitinib
country Germany
posting date18 Nov 2024
deadline31 Dec 2026
Open House Original Discount Agreements 2024-12 - Tofacitinib
country Germany
posting date18 Nov 2024
deadline31 Dec 2026
Open House Contracts For Multiple Active Ingredients/Active Ingredient Combinations
country Germany
posting date14 Jun 2024
deadline01 Jun 2026
Open House Contracts For Multiple Active Ingredients/Active Ingredient Combinations
country Germany
posting date14 Jun 2024
deadline01 Jun 2026
Conclusion Of Non-Exclusive Discount Agreements In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredient Tofacitinib
country Germany
posting date03 Oct 2023
deadline10 Sep 2025
Conclusion Of Non-Exclusive Discount Agreements In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredient Tofacitinib
country Germany
posting date03 Oct 2023
deadline10 Sep 2025

Share Share this page